NEWER BETA-BLOCKERS AND THE TREATMENT OF HYPERTENSION

被引:13
作者
MCAREAVEY, D
VERMEULEN, R
ROBERTSON, JIS
机构
[1] Department of Cardiology, Royal Infirmary, Edinburgh
[2] Janssen Research Foundation, Beerse
[3] Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong
关键词
ARTERIAL COMPLIANCE; BLOOD LIPIDS; CARDIAC HYPERTROPHY; CARDIAC OUTPUT; QUALITY OF LIFE;
D O I
10.1007/BF03029727
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Beta-adrenoceptor blocking agents are established as one of the principal classes of antihypertensive agents. Despite progressive refinements over the years, they still possess some unwanted effects, which limit their considerable value. In recent years a wide range of variations upon the beta-blocker theme has been developed. The full clinical advantages of the newer agents remain to be defined.
引用
收藏
页码:577 / 587
页数:11
相关论文
共 118 条
[71]  
Schulman S.P., Weiss J.L., Becker L.C., Et al., The effects of antihypertensive therapy on left ventricular mass in elderly patients, N Engl J Med, 322, pp. 1350-1356, (1990)
[72]  
Safar M.E., Pannier S.M., Soubies P.L., Et al., Intrinsic alterations of the arterial wall in hypertension and effect of antihypertensive therapy, Curr Opin Cardiol, 2, 1, pp. 26-32, (1987)
[73]  
Fouad-Tarazi F.M., Structural cardiac and vascular changes in hypertension: Response to treatment, Current Opinion in Cardiology, 2, pp. 782-786, (1987)
[74]  
Heagerty A.M., Bund S.J., Aalkjair C., Effects of drug treatment on human resistance arterial morphology in essential hypertension: Direct evidence for structural remodelling of resistance vessels, Lancet, 2, pp. 1209-1212, (1988)
[75]  
Simon A.C.H., Levenson J.A., Bouther J.E., Et al., Comparison of MK 421 and propranolol in mild to moderate hypertension and their effects on arterial and venous vessels of the forearm, Am J Cardiol, 53, pp. 781-785, (1984)
[76]  
Jern S., Reversibility of vascular hypertrophy in pharmacologically treated patients, Journal of Cardiovascular Pharmacology, 10, 5, pp. 112-115, (1987)
[77]  
Riddell J.G., Shanks R.G., Brogden R.W., Celiprolol, a preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina, Drugs, 34, pp. 438-458, (1987)
[78]  
Lundgren H., Bjorkman K., Keiding P., Et al., Diabetes in patients with hypertension receiving pharmacological treatment, Br Med J, 297, (1988)
[79]  
Skarfors E.T., Lithell H.O., Selinus I., Aberg H., Do antihypertensive drugs precipitate diabetes in predisposed men?, Br Med J, 298, pp. 1147-1152, (1989)
[80]  
Janka H.U., Ziegler A.G., Disselhoff G., Mehnert H., Influence of bisoprolol on blood glucose, glucosemia and hemoglobin A, in non-insulin-dependent diabetics, J Cardiovasc Pharmacol, 8, 11, pp. 96-99, (1986)